Cargando…

Nosocomial transmission clusters and lineage diversity characterized by SARS-CoV-2 genomes from two large hospitals in Paris, France, in 2020

France went through three deadly epidemic waves due to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), causing major public health and socioeconomic issues. We proposed to study the course of the pandemic along 2020 from the outlook of two major Parisian hospitals earliest involved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leducq, Valentin, Jary, Aude, Bridier-Nahmias, Antoine, Daniel, Lena, Zafilaza, Karen, Damond, Florence, Goldstein, Valérie, Duval, Audrey, Blanquart, François, Calvez, Vincent, Descamps, Diane, Marcelin, Anne-Geneviève, Visseaux, Benoit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8776803/ https://www.ncbi.nlm.nih.gov/pubmed/35058525 http://dx.doi.org/10.1038/s41598-022-05085-2

Ejemplares similares

Phylodynamics of SARS-CoV-2 in France, Europe, and the world in 2020
por: Coppée, Romain, et al.
Publicado: (2023)

Kaposi’s Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi’s Sarcoma
por: Jary, Aude, et al.
Publicado: (2021)

Decreased Sensitivity of Rapid Antigen Test Is Associated with a Lower Viral Load of Omicron than Delta SARS-CoV-2 Variant
por: Cocherie, Théophile, et al.
Publicado: (2022)

Epidemiology and Characteristics of SARS-CoV-2 Variants of Concern: The Impacts of the Spike Mutations
por: Cocherie, Théophile, et al.
Publicado: (2022)

Medical features of COVID-19 and influenza infection: A comparative study in Paris, France
por: Faury, Hélène, et al.
Publicado: (2021)

The 501Y.V2 SARS-CoV-2 variant has an intermediate viral load between the 501Y.V1 and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
por: Teyssou, Elisa, et al.
Publicado: (2021)

Harnessing Redox Disruption to Treat Human Herpesvirus 8 (HHV-8) Related Malignancies
por: Gothland, Adélie, et al.
Publicado: (2022)

Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
por: Marot, Stéphane, et al.
Publicado: (2021)

Author Correction: Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers
por: Marot, Stéphane, et al.
Publicado: (2021)

Investigation of healthcare-associated COVID-19 in a large French hospital group by whole-genome sequencing
por: Leducq, Valentin, et al.
Publicado: (2022)

SARS-CoV-2 variant-dependent inflammasome activation
por: Teyssou, Elisa, et al.
Publicado: (2023)

Seroprevalence and molecular diversity of Human Herpesvirus 8 among people living with HIV in Brazzaville, Congo
por: Malonga, Gervillien Arnold, et al.
Publicado: (2021)

Primaquine as a Candidate for HHV-8-Associated Primary Effusion Lymphoma and Kaposi’s Sarcoma Treatment
por: Gothland, Adélie, et al.
Publicado: (2022)

SARS-CoV-2 Neutralizing Responses in Various Populations, at the Time of SARS-CoV-2 Variant Virus Emergence: Evaluation of Two Surrogate Neutralization Assays in Front of Whole Virus Neutralization Test
por: Marot, Stephane, et al.
Publicado: (2022)

Evolution of viral quasispecies during SARS-CoV-2 infection
por: Jary, Aude, et al.
Publicado: (2020)

Poppers, by Inducing HHV-8 Virion Production, Can Act as a Promoter for HHV-8 Transmission in Men Who Have Sex With Men
por: Jary, Aude, et al.
Publicado: (2021)

Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali
por: Jary, Aude, et al.
Publicado: (2019)

Spike Gene Evolution and Immune Escape Mutations in Patients with Mild or Moderate Forms of COVID-19 and Treated with Monoclonal Antibodies Therapies
por: Jary, Aude, et al.
Publicado: (2022)

Émergence de variants E484 K suite à une monothérapie bamlanivimab chez des patients COVID-19 à haut risque d’évolution vers une forme sévère
por: Peiffer-Smadja, N., et al.
Publicado: (2021)

Emergence of E484K Mutation Following Bamlanivimab Monotherapy among High-Risk Patients Infected with the Alpha Variant of SARS-CoV-2
por: Peiffer-Smadja, Nathan, et al.
Publicado: (2021)

Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification
por: Désiré, Nathalie, et al.
Publicado: (2018)

Temporal dynamics of RSV shedding and genetic diversity in adults during the COVID-19 pandemic in a French hospital, early 2021
por: Coppée, Romain, et al.
Publicado: (2022)

Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatment
por: Marcelin, Anne-Genevieve, et al.
Publicado: (2014)

Viral epidemiology and SARS‐CoV‐2 co‐infections with other respiratory viruses during the first COVID‐19 wave in Paris, France
por: Le Hingrat, Quentin, et al.
Publicado: (2021)

High SARS-CoV-2 seroprevalence in HIV patients originating from sub-Saharan Africa in the Ile-de-France area: Seroprevalence of SARS-CoV-2 in HIV patients
por: ABDI, Basma, et al.
Publicado: (2022)

Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016
por: Visseaux, Benoit, et al.
Publicado: (2017)

Clinical presentation of Covid-19 in health care workers from a French University Hospital
por: Jary, Aude, et al.
Publicado: (2020)

Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants
por: Perrier, Marine, et al.
Publicado: (2018)

The Delta SARS-CoV-2 variant has a higher viral load than the Beta and the historical variants in nasopharyngeal samples from newly diagnosed COVID-19 patients
por: Teyssou, Elisa, et al.
Publicado: (2021)

Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2
por: Wirden, Marc, et al.
Publicado: (2020)

Sepsis 2016 Paris: Paris, France. 6-8 December 2016
por: Ingles, Marcia, et al.
Publicado: (2016)

Sepsis 2017 Paris: Paris, France. September 11–13, 2017
Publicado: (2017)

Petition to the Municipal Council of Paris, France
Publicado: (1882)

Comparative Performance of Anyplex II HPV28 and Cobas 4800 Human Papillomavirus (HPV) Assays for High-Risk HPV Detection in Self-collected Anal Samples
por: Delvallez, Gauthier, et al.
Publicado: (2023)

Alpha (B.1.1.7) and Delta (B.1.617.2 – AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage
por: Lebourgeois, Samuel, et al.
Publicado: (2022)

Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates
por: Visseaux, Benoit, et al.
Publicado: (2015)

Evaluation of three extraction-free SARS-CoV-2 RT-PCR assays: A feasible alternative approach with low technical requirements
por: Visseaux, Benoit, et al.
Publicado: (2021)

HIV-2 diversity displays two clades within group A with distinct geographical distribution and evolution
por: Visseaux, Benoit, et al.
Publicado: (2021)

Two large-scale analyses of Ty1 LTR-retrotransposon de novo insertion events indicate that Ty1 targets nucleosomal DNA near the H2A/H2B interface
por: Bridier-Nahmias, Antoine, et al.
Publicado: (2012)

Darunavir resistance spectrum in darunavir-na#239;ve patients harboring virological failure to antiretroviral therapy
por: Marcelin, AG, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_g2jkhq0t0vmctf4357ooj1c049